Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia

BACKGROUND: Mercaptopurine (6-MP) plays a pivotal role in treatment of childhood acute lymphoblastic leukemia (ALL); however, interindividual variability in toxicity of this drug due to genetic polymorphism in 6-MP metabolizing enzymes has been described. We determined the prevalence of the major ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Farfan, Mauricio J, Salas, Carolina, Canales, Cristina, Silva, Felipe, Villarroel, Milena, Kopp, Katherine, Torres, Juan P, Santolaya, María E, Morales, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012712/
https://www.ncbi.nlm.nih.gov/pubmed/24774509
http://dx.doi.org/10.1186/1471-2407-14-299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012712/
https://www.ncbi.nlm.nih.gov/pubmed/24774509
http://dx.doi.org/10.1186/1471-2407-14-299

Ejemplares similares